Mellozzan® (melatonin) approved in Turkey
EQL Pharma's key product Mellozzan® (tablets) has been approved for sale by the Turkish Medicines Agency. EQL's partner in Turkey, Abdi Ibrahim, will both manufacture and market Mellozzan® locally....
Media
Here you can take part in regulatory and non-regulatory press releases and presentations.
Read More
Press Releases
Exercise of warrants in EQL Pharma AB’s incentive programs
EQL Pharma AB (the ”Company“) today announces that two senior executives and one key employee in the Company have chosen to exercise 466,000 warrants in the Company’s outstanding incentive programs...
EQL Pharma's Chief Commercial Officer (CCO) sells shares to buy apartment for daughter
EQL Pharma's Chief Commercial Officer (CCO) Alexander Brising has recently sold shares for approximately SEK 2.1 million to pay for an apartment for his daughter who is starting university. "Not a ...